Abstract
Proper indications for a second surgical intervention in patients with colorectal cancer have always been a controversial subject. Surgeons find benefit in a second-look operation where a limited extent of cancer is discovered and resected with negative margins. However, a negative exploratory laparotomy or an intervention that is unable to achieve an R0 resection provides little or no benefit. Unfortunately, this type of intervention may place the patient in a worse condition, leading to morbidity or mortality. This manuscript attempts to define clinical parameters of primary colorectal cancer that are associated with a pattern of recurrence and that can be definitively addressed by second-look surgery. Also, new surgical technologies that may assist in achieving a potentially curative resection of local-regional recurrence are described. Cytoreductive surgery with peritonectomy and perioperative intraperitoneal chemotherapy with hyperthermia is presented as a new treatment option for reoperative surgery. A new management plan utilized in patients at high risk for local-regional recurrence may result in a high likelihood of conversion of a second-look cancer-positive patient to a long-term survivor.
Similar content being viewed by others
References
Osteen RT, Guyton S, Steele G Jr, Wilson RE (1980) Malignant intestinal obstruction. Surgery 87:611–615
Walsh HPJ, Schofield PF (1984) Is laparotomy for small bowel obstruction justified in patients with previously treated malignancy? Br J Surg 71: 933–935
Spears H, Petrelli NJ, Herrera L, Mittelman A (1998) Treatment of bowel obstruction after operation for colorectal carcinoma. Am J Surg 155: 383–386
Butler JA, Cameron BL, Morrow M, Kahng K et al (1991) Small bowel obstruction in patients with a prior history of cancer. Am J Surg 162:624–628
Gwin JL, Hoffman JP, Eisenberg BL (1993) Surgical management of nonhepatic intra-abdominal recurrence of carcinoma of the colon. Dis Colon Rectum 36:540–544
Gilbertsen VA, Wangensteen OH (1962) A summary of thirteen years’ experience with the second look program. Surg Gynecol Obstet 114:438–442
Minton JP, Hoehn JL, Gerber DM et al (1985) Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 55: 1284–1290
Griffen WO Jr, Humphrey L, Sosin H (1969) The prognosis and management of recurrent abdominal malignancies. Curr Probl Surg Apr:1–43
Wangensteen OH (1949) Cancer of the colon and rectum; with special reference to earlier recognition of alimentary tract malignancy; secondary delayed re-entry of the abdomen in patients exhibiting lymph node involvement; subtotal primary excision of the colon; operation in obstruction. Wis Med J 48:591–597
Sugarbaker PH, Zamcheck N, Moore FD (1976) Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer. Cancer 38:2310–2315
Steele G Jr, Zamcheck N, Wilson R et al (1980) Results of CEA-initiated second-look surgery for recurrent colon cancer. Am J Surg 139:544–548
Attiyeh FF, Stearns MW Jr (1981) Second-look laparotomy based on CEA elevations in colorectal cancer. Cancer 47:2119–2125
Goldberg RM, Fleming TR, Tangen CM et al (1998) Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection. Ann Intern Med 129: 27–35
Gunderson LL, Sosin H (1974) Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 34: 1278–1292
Lofgren EP, Waugh JM, Dockerty MB (1957) Local recurrence of carcinoma after anterior resection of the rectum and the sigmoid. Arch Surg 74: 825–838
Turnbull RB, Kyle K, Watson FR et al (1967) Cancer of the colon: The influence of the no-touch isolation technic on survival rates. Ann Surg 166: 420–427
Haugstvedt TK, Viste A, Eide GE et al (1993) Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. Br J Surg 80:475–478
Sugarbaker PH, Gianola FJ, Speyer JL et al (1985) Prospective randomized trial of intravenous versus intraperitoneal 5 fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 98:414–421
Sugarbaker PH (1996) Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In: Sugarbaker PH (ed). Peritoneal carcinomatosis: principles of management. Kluwer, Boston, pp 79–100
Alexander HR, Allegra CJ, Lawrence TS (2001) Metastatic cancer to the liver. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles & practice of oncology, 6th edn. Lippincott, Philadelphia, pp 2690–2713
Yan TD, Black D, Savady R et al (2006) Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 24:4011–4019
Elias D, Gilly F, Boutitie F et al (2009) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63–68
Swanson RS, Compton CC, Stewart AK et al (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65
Rich T, Gunderson LL, Galdabini J et al (1983) Clinical and pathologic factors influencing local failure after curative resection of carcinoma of the rectum and rectosigmoid. Cancer 52:1317–1327
Sugarbaker PH (1999) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43(Suppl):S15–S25
Sugarbaker PH, Gunderson LL, Wittes RE (1985) Colorectal cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, Vol. 1, 2nd edn. JB Lippincott, Philadelphia, pp 795–866
Rekhraj S, Aziz O, Prabhudesai S et al (2007) Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: A meta-analysis. Ann Surg Oncol 15:60–68
da Silva RG, Sugarbaker PH (2006) Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 203:878–886
Sugarbaker PH, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124–132
Elias D, Goere D, Di Pietrantonio D et al (2008) Results of systematic second-look surgery in pts at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 247:445–450
Sugarbaker PH (2008) Options for the management of peritoneal carcinomatosis, patients have the right to be informed. Leadership Medica 269:28–35
Sugarbaker PH (2008) Comprehensive management of disseminated colorectal cancer. Ann Surg Oncol 15:3327–3330
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sugarbaker, P.H. Revised guidelines for second-look surgery in patients with colon and rectal cancer. Clin Transl Oncol 12, 621–628 (2010). https://doi.org/10.1007/s12094-010-0567-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-010-0567-8